FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Realm US

12,851 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 10,870

 

Start Prev Rows 7600 - 7800 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1219.134Sleep Related Symptom for Positive Airway Pressure Device Use Evaluationactive2022-03hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7753Directionality of Link (TB)active2017-12sct
signal.core.r4R4questionnaire-ccars-disabilitiesQuestionnaire CCARS Disabilitiesdraft1pahl7
us.nlm.vsacR42.16.840.1.113762.1.4.1099.49Disability Status Assessmentactive2024-08hl7loinc
hl7.fhir.us.military-serviceR4military-service-discharge-status-vsDischarge Status Value Setactive2023-05hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.909Diseaseactive2019-12sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7970Disease Stage (Brucellosis)active2021-01sct tho
fhir.org.nz.ig.baseR4dhbDistrict Health Board Identiferactive2025-06hl7
hl7.fhir.us.splR5splDocumentCodesSPL Document Codestrial-use1brr2025-07hl7loinc
signal.core.r4R4signal-filerepo-docreviewstatusSignal FileRepo DocStatusdraft2023-09hl7
us.nlm.vsacR42.16.840.1.113762.1.4.1222.672Entrapment Neuropathyactive2024-07hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.1444.5.228Low Emetic Risk Intravenous Antineoplastic Agentactive2025-04hl7vsac
us.nlm.vsacR41.3.6.1.4.1.6997.4.1.2.271.12.37696.1.1.999.654Proton Pump Inhibitors not including for H. pylori treatmentactive2019-04hl7rx
fhir.org.nz.ig.baseR4domicile-codeDomicile Codeactive2025-06hl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7927Dose Unit (STD)active2020-01ucum sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7630Drinking Water (FDD)active2017-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.1071Drug Susceptibility Test Result Nameactive2008-01loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.1102Drug Active Ingredientsactive2008-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.1108Drug Classes (NDF-RT)active2008-01tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.1106Drug Manufacturers (NDC)active2008-01ndc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7467Drug Disease Interaction (Dengue)active2016-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7055Antituberculosis Drugs (TB)active2013-01rx
hl7.fhir.us.breast-radiologyR4DuctAbnormalityTypeVSDuct Abnormality Type ValueSetactive2022-12hl7fhir
us.nlm.vsacR42.16.840.1.113883.1.11.14914Race Value Setactive2024-06hl7oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7926Number of Cigarettes Smoked per Day (CO)active2019-01sct tho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1078.292Metabolic syndrome I10active2023-09hl7icd
hl7.fhir.us.registry-protocolsR4STEMIFirstNotedSTEMI or STEMI Equivalent First Notedactivecic2023-11hl7fhir
us.nlm.vsacR42.16.840.1.113762.1.4.1260.232EGFR Molecular Variants Amivantamab PMactive2024-05hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1260.231EGFR Amivantamab Molecular Variantsactive2024-05hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1260.56Early and Limited Stageactive2023-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1260.57Early Stage IIB or loweractive2023-11hl7ncit
hl7.fhir.us.registry-protocolsR4ElectrocardiacAbnormalityTypeElectrocardiac Abnormality Typeactivecic2023-11hl7fhir sct
hl7.fhir.us.registry-protocolsR4ElectrocardiacAssessmentMethodElectrocardiac Assessment Methodactivecic2023-11hl7fhir sct
hl7.fhir.us.registry-protocolsR4ElectrocardiacAssessmentResultsElectrocardiac Assessment Resultsactivecic2023-11hl7fhir sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.985Employment Statusactive2008-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.1011Data Subtypeactive2008-01
us.cdc.phinvadsR42.16.840.1.114222.4.11.1012Type of Dataactive2008-01
ca.on.dhdr.r4.v4R4encounter-classEncounter Classactivehl7tho
fhir.cdc.opioid-cds-r4R4condition-encounter-diagnosis-categoryEncounter Diagnosis Condition Categoryactive2023-05hl7
hl7.fhir.us.directory-queryR4EndpointConnectionTypeVSEndpoint Connection Types Value Setactive2022-12hl7fhir tho
hl7.fhir.us.davinci-pdex-plan-netR4EndpointConnectionTypeVSEndpoint Connection Types VStrial-usefm2025-02hl7fhir tho
hl7.fhir.us.ndhR4EndpointConnectionTypeVSEndpoint Connection Types Value Settrial-usepa2025-07hl7fhir ihe tho
hl7.fhir.us.ndhR4EndpointFhirMimeTypeVSEndpoint FHIR Mimetype Value Settrial-usepa2025-07hl7ietf
hl7.fhir.us.ndhR4EndpointIheSpecificConnectionTypeVSEndpoint IHE Specific Connection Types Value Settrial-usepa2025-07hl7ihe
hl7.fhir.us.directory-queryR4EndpointPayloadTypeVSEndpoint Payload Type Value Setactive2022-12hl7fhir
hl7.fhir.us.davinci-pdexR4EndpointPayloadTypeVSEndpoint Payload Type Value Settrial-use2fm2025-06hl7fhir
hl7.fhir.us.davinci-pdex-plan-netR4EndpointPayloadTypeVSEndpoint Payload Types VStrial-usefm2025-02hl7fhir
hl7.fhir.us.ndhR4EndpointPayloadTypeVSEndpoint Payload Type Value Settrial-usepa2025-07hl7tho
signal.core.r4R4questionnaire-ccars-enrollment-payerQuestionnaire CCARS Enrollment Payerdraft1pahl7
us.nlm.vsacR42.16.840.1.113762.1.4.1095.58Nutrition Order Item Groupingactive2018-04hl7vsac
us.cdc.phinvadsR42.16.840.1.114222.4.11.3129Injury Occurred Environment (VPD)active2008-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7674Lab Test Interpretation (Trich)active2018-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7744Lab Test Interpretation (TB)active2019-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7734Lab Test Interpretation (RIBD)active2018-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7867Test Result (C. auris)active2019-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3252Lab Test Interpretation (Flu)active2009-01sct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7823Lab Test Interpretation (Legionellosis)active2018-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7334Lab Test Interpretation (Pertussis)active2016-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3301Lab Test Interpretation (VPD)active2022-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3263Lab Test Interpretation (Pediatric Flu)active2009-01sct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3251Lab Test Procedure (Flu)active2009-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3309Lab Test Procedure (Malaria)active2016-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.3302Lab Test Procedure (Measles)active2010-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3306Lab Test Procedure (Mumps)active2010-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7545Lab Test Type (Babesiosis)active2017-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.3262Lab Test Procedure (Pediatric Flu)active2009-01sct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7673Lab Test Type (Trich)active2018-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7775Lab Test Type (RIBD)active2019-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7835Lab Test Type (TBRD)active2022-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7863Lab Test Type (C. auris)active2018-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7743Lab Test Type (TB)active2018-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7948Lab Test Type (COVID-19)active2021-01oid loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1146.227Lyme Disease (Disorders) (ICD10CM)active2023-01hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1146.226Lyme Disease (Disorders) (SNOMED)active2025-02hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3015Ethnicity Group including Unknownactive2008-01tho oid
fhir.org.nz.ig.baseR4ethnicityfullEthnicity of a person (full)active2025-06hl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.3359Evaluation Findingactive2010-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.1068Eventactive2010-01sct
hl7.fhir.us.birthdefectreportingR4bdr-eventtypesBirth Defect Report Event Typesactivepher2025-06hl7loinc
fhir.ops-esaviR4NombreESAVIVSCódigo nombre ESAVIactive2021-03hl7internal
us.cdc.phinvadsR42.16.840.1.114222.4.11.3293Evidence Of Immunity (IIS)active2010-01sct
signal.core.r4R4device-actionProcedure Device Action Codesdraftpc2019-10hl7sct
hl7.fhir.us.military-serviceR4military-service-combat-episode-mission-vsCombat Episode Mission Value Setactive2023-05hl7fhir
hl7.fhir.us.davinci-vbprR4measure-stratifier-exampleMeasure Stratifier Exampletrial-use1cqi2025-07hl7fhir
hl7.fhir.us.pcoR4what-matters-codes-exampleWhat Matters Codes Exampledraft2pc2025-03hl7fhir sct
hl7.fhir.us.pcoR4pco-goal-barrier-types-example-vsGoal Barrier Types Exampledraft2pc2025-03hl7sct
hl7.fhir.us.pcoR4wellbeing-domains-exampleWell-Being Domains Exampledraft2pc2025-03hl7fhir
hl7.fhir.us.davinci-crdR4serviceRequestCodesCRD Service Request Codes Value Settrial-use3fm2025-07hl7sct cpt cms loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1078.680GLP1RA DM ASCVDactive2024-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.2000.5Percutaneous Coronary Interventionactive2022-03hl7vsac
hl7.fhir.us.registry-protocolsR4ValvularRegurgitationValvular Regurgitationactivecic2023-11hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7369Present on Admission (NCHS)active2015-01sct tho
us.nlm.vsacR42.16.840.1.113762.1.4.1032.296SCT Findings 202209active2024-03hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.309SCT Findings 202309active2024-03hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.311SCT Procedures 202209active2024-03hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.312SCT Procedures 202309active2024-03hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.8017Exposure Source (Brucellosis)active2021-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7198Transmission Category (STD)active2020-01oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7978Exposure Risk (Brucellosis)active2020-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7942Exposure Setting (COVID-19)active2020-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7994Exposure Type (Leptospirosis)active2020-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.1024Extended Priority Codes (HL7)active2008-01tho
hl7.fhir.us.davinci-crdR4CMSMappableLocationCodesCMS Mappable Location Codestrial-use1fm2025-07hl7fhir tho
us.nlm.vsacR42.16.840.1.113762.1.4.1178.97AHA GWTG Long COVID19 SNOMEDCTactive2024-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.98AHA GWTG Long COVID19 ICD10CMactive2024-10hl7icd
signal.core.r4R4questionnaire-ccars-aggression-danger-to-others-ratingQuestionnaire CCARS Aggression Danger To Others Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-role-performance-ratingQuestionnaire CCARS Role Performance Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-interpersonal-ratingQuestionnaire CCARS Interpersonal Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-multiple-issues-ratingQuestionnaire CCARS Multiple Issues Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-psychosis-ratingQuestionnaire CCARS Psychosis Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-depressive-issues-ratingQuestionnaire CCARS Depressive Issues Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-suicide-danger-to-self-ratingQuestionnaire CCARS Suicide Danger To Others Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-social-support-ratingQuestionnaire CCARS Social Support Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-overall-level-of-functioning-ratingQuestionnaire CCARS Overall Level Of Functioning Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-legal-ratingQuestionnaire CCARS Legal Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-overall-recovery-ratingQuestionnaire CCARS Overall Recovery Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-hope-ratingQuestionnaire CCARS Hope Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-activity-involvement-ratingQuestionnaire CCARS Overall Activity Involvement Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-cognition-ratingQuestionnaire CCARS Cognition Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-empowerment-ratingQuestionnaire CCARS Empowerment Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-socialization-ratingQuestionnaire CCARS Socialization Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-physical-health-ratingQuestionnaire CCARS Physical Health Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-alcohol-use-ratingQuestionnaire CCARS Alcohol Use Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-drug-use-ratingQuestionnaire CCARS Drug Use Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-family-ratingQuestionnaire CCARS Family Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-self-care-basic-needs-ratingQuestionnaire CCARS Self Care Basic Needs Ratingdraft1pahl7
signal.core.r4R4questionnaire-ccars-security-supervision-ratingQuestionnaire CCARS Security Supervision Ratingdraft1pahl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7621Signs and Symptoms (FDD)active2017-01sct tho
signal.core.r4R4v2-2.7-0360v2 table 0360, Version 2.7draft1pahl7tho
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.11.1094Ehlers Danlos Syndromeactive2018-03hl7sct
us.nlm.vsacR42.16.840.1.113883.3.464.1003.113.12.1047Ehlers Danlos Syndromeactive2024-01hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1206.41TricyclicAntidepressantsactive2021-07hl7rx
us.cdc.phinvadsR42.16.840.1.114222.4.11.1056Vaccination Location (CRA)active2008-01sct tho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1206.35Assymetry Symptomsactive2021-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1206.42Benzodiazepinesactive2021-07hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1206.43LoopDiureticsactive2021-07hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1206.44Antiepilepticsactive2021-07hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1206.45Antipsychoticsactive2021-07hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1206.36Hemiplegia Symptomsactive2021-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1206.37Leg Weakness Symptomsactive2021-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1206.38Osteopenia Symptomsactive2021-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1206.39Stroke Symptomsactive2021-07hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1206.40Vestibular Symptomsactive2021-07hl7icd
us.cdc.phinvadsR42.16.840.1.113883.1.11.19579Family Member Value Setactive2009-01tho
fhir.cdc.opioid-cds-r4R4fentanyl-type-medicationsFentanyl-type medicationsactive2025-02hl7
hl7.fhir.us.breast-radiologyR4FibroAdenomaAbnormalityTypeVSFibroAdenoma Abnormality Type ValueSetactive2022-12hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.3382Query Priority (IIS)active2010-01tho
hl7.fhir.us.vrdrR4vrdr-filing-format-vsFiling Format ValueSetactivepher2024-10hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.7769Final Treatment Outcome (TB)active2017-12sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3144Treatment Outcome Tetanus (VPD)active2008-01sct tho
hl7.fhir.us.davinci-pctR4PCTFinancialTypeVSPCT Financial Type Value Settrial-usefm2025-06hl7fhir
fhir.cdc.opioid-cds-r4R4hospice-findingHospice Findingactive2023-05hl7sct
fhir.cdc.opioid-cds-r4R4pdmp-data-reviewed-findingPDMP data reviewed findingactive2023-05hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1121.6Most/Moderately Effective Contraceptive SNOMED Findingsactive2024-06hl7sct
us.cdc.phinvadsR42.16.840.1.113883.10.14.1.1.13.7Placental Conditions (HL7)active2017-01sct
hl7.fhir.us.registry-protocolsR4FirstCardiacArrestRhythmFirst Cardiac Arrest Rhythmactivecic2023-11hl7fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.3587Flu Activity Codeactive2010-01sct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3255Case Contact Signs and Symptoms (Flu)active2009-01sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7787Food Allergy (Listeria)active2018-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3070Botulism Food Source Type (FDD)active2008-01tho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1166.167Contraceptive Implant LOINCactive2021-10hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.140IUD Devicesactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.130Contraceptive Implants RXNORM Medicationsactive2021-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1166.131Injectable Contraceptive RXNORM Medicationsactive2021-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1166.132Oral Contraceptive Pills RXNORM Medicationsactive2025-04hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1166.129Contraceptive Ring RXNORM Medicationsactive2021-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1166.139IUD Provision Proceduresactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.192Contraceptive Implant SNOMED Surveillance Proceduresactive2021-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.138IUD Surveillanceactive2021-10hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.85Intrauterine Devices RXNORM Medicationsactive2021-10hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1166.205Prenatal Care Bundle Visitsactive2021-11hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.133Pregnancy Related Diagnosesactive2021-10hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.103Female Sterilization HCPCS Devicesactive2021-10hl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1166.105Female Sterilization ICD10CM Provision Encountersactive2021-10hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1166.109Sterilization SNOMED Findingsactive2024-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.134Female Sterilization SNOMED Provision Proceduresactive2024-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.142Female Sterilization Provision Proceduresactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.93Female Sterilization CPT Provision Proceduresactive2021-10hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1166.98Female Sterilization LOINCactive2021-10hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.99Female Sterilization ICD10PCS Provision Proceduresactive2021-10hl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1166.118Infecund Not for Contraceptive Reasons CPT Proceduresactive2024-10hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1166.119Infecund Not for Contraceptive Reasons HCPCS Proceduresactive2021-10hl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1166.97Infecund Not for Contraceptive Reasons ICD10CMactive2021-10hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1166.125Non Live Birth Diagnoses ICD10CMactive2021-10hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1166.126Non Live Birth Diagnoses SNOMEDactive2025-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.127Non Live Birth CPT Proceduresactive2022-06hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1166.128Non Live Birth ICD10PCS Proceduresactive2021-10hl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1166.136Non Live Birth Proceduresactive2021-10hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.137Non Live Birth Diagnosesactive2021-10hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.204Prenatal Care Bundle CPTactive2021-11hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1166.120Prenatal Care Visits CPTactive2021-10hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1166.121Prenatal Care Visits HCPCSactive2021-10hl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1166.122Prenatal Care Visits SNOMEDactive2021-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.135General Prenatal Care Visitsactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.111Prenatal Care Specific Visits CPTactive2021-10hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1166.112Prenatal Care Specific Visits HCPCSactive2021-10hl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1166.113Prenatal Care Specific Visits SNOMEDactive2021-10hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.114Prenatal Care Specific Visitsactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.110Pregnancy Bundle Visitsactive2021-10hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.168Pregnancy Bundle CPTactive2021-10hl7cpt